Cyto Pulse Sciences, Inc.

Cyto Pulse Sciences was acquired by Cellectis in September, 2010 and is no longer in operation. It was a clinical-stage medical device and treatment development company dedicated to advancing quality of life through novel electric field based technologies for oncology, gene therapy and infectious disease applications. Cyto Pulse's IP portfolio primarily focused on in vivo DNA vaccine delivery systems, tools for mAb discovery research, and large-scale cell transfection for GMP production environments.

Specialties : 

Status: 

Acquired

Industries: 

Employee Count Range: 

2-10

Company type: 

Privately Held

Share this page